ArticleThe oncologist2025

A multicenter retrospective study of PD-1 blockade plus chemotherapy as first-line therapy in advanced hepatoid adenocarcinoma of the stomach.

Jingru Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.